UPDATE 1-Novartis hikes 2019 outlook as gene therapy, skin drugs shine [Reuters]
JULIUS BAER GRP UNSP/ADR (JBAXY)
NASDAQ:AMEX Investor Relations:
juliusbaer.com/group/en/investors
Company Research
Source: Reuters
Novartis hikes 2019 outlook as gene therapy, skin drugs shine - Reuters 2 Min Read ZURICH (Reuters) - Novartis ( NOVN.S ) on Tuesday boosted its full-year targets, as sales of medicines including psoriasis drug Cosentyx and gene therapy Zolgensma helped the Swiss drugmaker surpass analysts’ third-quarter expectations. Sales are now seen growing at a high single-digit percentage rate at constant currencies, from the mid-to-high single digit rate forecast from July. Core operating income is now seen growing at a mid- to high-teen rate, up from low double-digit to mid-teen percentages. Third-quarter core net income rose 17% to $3.2 billion. Sales were $12.2 billion, well beyond the $11.7 billion average in a Refinitiv poll. The shares were seen rising more than 2%, according to pre-market indicators provided by Bank Julius Baer. JBPRE01 Chief Executive Vas Narasimhan has now raised targets for the third time this year, matching cross-town rival Roche’s ( ROG.S ) guidance moves, amid
Show less
Read more
Impact Snapshot
Event Time:
JBAXY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JBAXY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JBAXY alerts
High impacting JULIUS BAER GRP UNSP/ADR news events
Weekly update
A roundup of the hottest topics
JBAXY
News
- Sale of Kairos to Anima Successfully Completed [Yahoo! Finance]Yahoo! Finance
- Annual General Meeting 2024 of Julius Baer Group Ltd. [Yahoo! Finance]Yahoo! Finance
- Julius Baer: Shares Still Good Value After Private Debt Debacle [Seeking Alpha]Seeking Alpha
- Tax Evasion Through Swiss Banks Alleged Against Florida Resident [Forbes]Forbes
- Bitcoin Tops $73,000 After Record-Breaking Billion-Dollar ETF Inflow [zero hedge]zero hedge